Applications of 1-(Fmoc-Amino)Cyclohexanecarboxylic Acid in Industrial Manufacturing

1-(Fmoc-Amino)Cyclohexanecarboxylic acid serves as a key building block in several high-value industrial sectors. Our manufacturing expertise ensures reliable supply for complex synthesis workflows used by specialist producers worldwide. Below we detail its main downstream industrial applications, compliance requirements, mixing ratios, process roles, and typical end products.

1. Peptide Active Pharmaceutical Ingredient (API) Synthesis

This compound is widely used as a protected amino acid reagent for solid-phase peptide synthesis (SPPS) in API production. Its rigid cyclohexyl structure provides enhanced peptide stability, favored in new chemical entities and generic peptide APIs. Downstream manufacturers deploy this intermediate for assembling complex peptide backbones with specific conformational demands. Compliant producers integrate this material in large-scale and GMP-grade peptide API lines, focusing on injectable and oral dosage forms where sequence integrity is critical.

Industry compliance standards

• ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
• USP <823>: Peptides and Polypeptides
• EU GMP Part II: Basic Requirements for Active Substances
• Chinese Pharmacopoeia (ChP) peptide standards

Typical usage ratio

• Used at 0.8–1.2 molar equivalents per coupling cycle, depending on sequence complexity and resin loading. Process chemists optimize equivalents based on purity targets and scale.

Downstream process integration

• Charged during each coupling step of automated or manual Fmoc-SPPS. Follows washing and Fmoc deprotection stages to assemble target peptides on solid support.

Final product types

• Generic peptide APIs (eg. bivalirudin, octreotide)
• Innovative peptide therapeutics
• Diagnostic peptide probes
• Research-grade synthetic peptides

2. Peptide-Based Cosmetic Ingredient Manufacturing

Cosmetic manufacturers source this building block for production of palmitoylated or amidated peptides used in skincare and anti-aging products. Its hydrophobic backbone facilitates integration into amphiphilic peptide structures, improving formulation behavior in emulsions and creams. The raw material enters cGMP or ISO 22716-compliant cosmetic reagent synthesis and is favored for batches targeted at EU, US, and Asian cosmeceutical markets.

Industry compliance standards

• ISO 22716: Cosmetics — Good Manufacturing Practices
• REACH Regulation (EC) No 1907/2006 for safe chemical management
• Cosmetic Ingredient Review (CIR) safety monographs

Typical usage ratio

• 0.9–1.1 eq per coupling in peptide synthesis protocols. Final peptide content in formulations typically ranges from 100 ppm to 2000 ppm after post-synthetic modifications.

Downstream process integration

• Inserted during solid-phase peptide coupling phase before further derivatization. Peptide solution is then hydrolyzed, purified, and blended into cosmetic bases via cold or hot process methods.

Final product types

• Peptide-enriched serums
• Anti-wrinkle creams
• Skin-firming emulsions
• Hair growth promoting lotions

3. Custom Peptide Synthesis for Research and Diagnostics

CROs and academic labs purchase 1-(Fmoc-Amino)Cyclohexanecarboxylic acid for the production of structurally defined peptides required in fundamental research, cell culture studies, and bioanalytical assay development. It is favored in fluorescence-tagged or cyclized peptide syntheses demanding backbone conformational rigidity. Applications require precise control of impurity profiles and chromatographic traceability from raw to finished synthetic peptides.

Industry compliance standards

• ISO 9001:2015 for laboratory reagent production
• OECD Principles of Good Laboratory Practice (GLP)
• Supplier must provide detailed Certificate of Analysis (CoA) with HPLC, MS, NMR data

Typical usage ratio

• 1.0 eq per amino acid addition cycle, adjusted for intended yield and coupling efficiency. Variations exist based on resin and peptide length.

Downstream process integration

• Used in programmable solid-phase or solution-phase peptide synthesizers. Incorporated during the sequential extension of custom peptide sequences prior to cleavage and purification.

Final product types

• Peptide standards for HPLC/LC-MS
• Bioassay substrate peptides
• Fluorescent-labeled research peptides
• Antibody epitope libraries

4. Modified Cyclohexyl Derivative Intermediates in Fine Chemical Synthesis

Specialty chemical manufacturers employ this Fmoc-protected monomer as a precursor for further cyclohexyl derivative elaboration, supporting the production of advanced intermediates for agrochemical and material science applications. The stereo-defined cyclohexane scaffold is preferred in certain polymer-modified resins and catalysts due to its conformational constraint and compatibility with multi-step synthesis environments. Downstream customers require traceable raw materials for regulated sectors.

Industry compliance standards

• ISO 9001:2015 certified manufacturing
• EU REACH registration for new chemical entities
• SILVEX process compliance for specific catalyst supports

Typical usage ratio

• 0.7–1.2 eq per condensation or derivatization step, selected based on desired substitution pattern and downstream yield considerations.

Downstream process integration

• Added to batch reactors during intermediate generation or as a key component in combinatorial parallel synthesis for library production. Reactant is introduced prior to Fmoc deprotection and further functionalization steps.

Final product types

• Cyclohexyl-functionalized performance polymers
• Specialty resin intermediates
• Agrochemical building blocks
• Chiral catalysts and ligand precursors